Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 27 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Raptamer-drug Conjugates As Molecularly Targeted Cancer Therapeutics
Stephanie P. Vega, Nancy E. Ward,Uksha Saini, Leniher Castan-Chibas,Garima Kaushik,Daniel Ciznadija,Dev Chatterjee, Michael J. Heffernan,Atul Varadhachary,Michael Ritchie
Cancer Researchno. 6_Supplement (2024): 3210-3210
Cited0Views0Bibtex
0
0
FIS103, a Novel SULT1A1-dependent Prodrug, Demonstrates Potent Antitumor Activity in Renal Cell Carcinoma
Ross A. Hamilton,Uksha Saini, Mai Tran, Christopher J. Foley, Pooja Enagala, Leniher C. Chibas, Disha Chatterjee,Stephanie P. Vega,Dev Chatterjee,Atul Varadhachary
crossref（2024）
Cited0Views0Bibtex
0
0
Development of a Prodrug for Treating Renal Cancer Carcinoma
Ross Hamilton, Leniher Castan, Stephanie Vega,Atul Varadhachary,Dev Chatterjee
Cancer Researchno. 7_Supplement (2023): 1630-1630
Cited0Views0Bibtex
0
0
Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19
Atul Varadhachary,Dev Chatterjee, Javier Garza, R Patrick Garr,Christopher Foley, Andrea Letkeman, John Dean, David Haug, Juliet Breeze,Robbyn Traylor, Andrew Malek,Rohan Nath, Leo Linbeck
medRxiv : the preprint server for health sciences (2020)
Cited61Views0WOSBibtex
61
0
Salivary Anti-Sars-cov-2 IgA As an Accessible Biomarker of Mucosal Immunity Against COVID-19
Atul Varadhachary,Dev Chatterjee, Javier Garza, R. Patrick Garr,Christopher Foley, Andrea Letkeman, John Dean, David Haug, Juliet Breeze,Robbyn Traylor, Andrew Malek,Rohan Nath, Leo Linbeck
semanticscholar（2020）
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 27

#Citation: 4397

H-Index: 14

G-Index: 20

Sociability: 4

Diversity: 2

Activity: 1

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn